Article metrics
PDF
Other content recommended for you
- Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia
- Proceduralisation, choice and parental reflections on decisions to accept newborn bloodspot screening
- Information and consent for newborn screening: practices and attitudes of service providers
- Challenges of using whole genome sequencing in population newborn screening
- Cross-sectional prospective feasibility study of newborn screening for sickle cell anaemia and congenital hypothyroidism in Guyana
- Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol
- High 17-hydroxyprogesterone level in newborn screening test for congenital adrenal hyperplasia
- Primary congenital hypothyroidism: challenges in a low-income country without paediatric endocrinologist and universal newborn screening
- Incidence and clinical features of congenital adrenal hyperplasia in Great Britain
- Diagnostic potential of stored dried blood spots for inborn errors of metabolism: a metabolic autopsy of medium-chain acyl-CoA dehydrogenase deficiency